RIM
AMRI

Ranger Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Ranger Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-103,770
Closed -$2.25M – 151
2017
Q2 		$2.25M Sell
103,770
-19,760
-16% -$359K 0.16% 58
2017
Q1 		$1.73M Buy
123,530
+18,310
+17% +$300K 0.13% 65
2016
Q4 		$1.97M Buy
105,220
+23,570
+29% +$401K 0.14% 74
2016
Q3 		$1.35M Buy
81,650
+6,250
+8% +$92.6K 0.1% 91
2016
Q2 		$1.01M Buy
75,400
+3,050
+4% +$44.5K 0.06% 96
2016
Q1 		$1.11M Buy
72,350
+2,350
+3% +$36.8K 0.07% 96
2015
Q4 		$1.39M Sell
70,000
-5,170
-7% -$98.3K 0.08% 81
2015
Q3 		$1.31M Buy
75,170
+5,510
+8% +$112K 0.07% 84
2015
Q2 		$1.41M Buy
69,660
+24,760
+55% +$478K 0.07% 86
2015
Q1 		$790K Buy
44,900
+1,350
+3% +$23K 0.04% 97
2014
Q4 		$709K Buy
43,550
+12,710
+41% +$233K 0.04% 101
2014
Q3 		$681K Buy
+30,840
New +$631K 0.04% 92

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Ranger Investment Management's AMRI Position: Q3 2017 in Review

Ranger Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 103,770 shares — an estimated $2.25M sold.

Ranger Investment Management first reported a position in AMRI in Q3 2014 and held it in 12 quarters. The position peaked at $2.25M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Ranger Investment Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Ranger Investment Management sold 103,770 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.25M.
  • Ranger Investment Management first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 12 quarters.
  • Ranger Investment Management's Albany Molecular Research Inc position peaked at $2.25M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Ranger Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.